J. Exp. Med., Volume 189, Number 2, January 18, 1999 279-288

Regulatory T Cells in the Control of Autoimmunity: the Essential Role of  Transforming Growth Factor  and Interleukin 4 in the Prevention of Autoimmune Thyroiditis in Rats by Peripheral CD4⁺CD45RC Cells and CD4⁺CD8 Thymocytes

By Benedict Seddon and Don Mason

From the Medical Research Council Cellular Immunology Unit, Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, United Kingdom

Previous studies have shown that induction of autoimmune diabetes by adult thymectomy and split dose irradiation of PVG.RT1^u rats can be prevented by their reconstitution with peripheral CD4⁺CD45RCTCR-/⁺RT6⁺ cells and CD4⁺CD8 thymocytes from normal syngeneic donors. These data provide evidence for the role of regulatory T cells in the prevention of a tissue-specific autoimmune disease but the mode of action of these cells has not been reported previously. In this study, autoimmune thyroiditis was induced in PVG.RT1^c rats using a similar protocol of thymectomy and irradiation. Although a cell-mediated mechanism has been implicated in the pathogenesis of diabetes in PVG.RT1^u rats, development of thyroiditis is independent of CD8⁺ T cells and is characterized by high titers of immunoglobulin (Ig)G1 antithyroglobulin antibodies, indicating a major humoral component in the pathogenesis of disease. As with autoimmune diabetes in PVG.RT1^u rats, development of thyroiditis was prevented by the transfer of CD4⁺CD45RC and CD4⁺CD8 thymocytes from normal donors but not by CD4⁺CD45RC⁺ peripheral T cells. We now show that transforming growth factor (TGF)- and interleukin (IL)-4 both play essential roles in the mechanism of this protection since administration of monoclonal antibodies that block the biological activity of either of these cytokines abrogates the protective effect of the donor cells in the recipient rats. The prevention of both diabetes and thyroiditis by CD4⁺CD45RC peripheral cells and CD4⁺CD8 thymocytes therefore does not support the view that the mechanism of regulation involves a switch from a T helper cell type 1 (Th1) to a Th2-like response, but rather relies upon a specific suppression of the autoimmune responses involving TGF- and IL-4. The observation that the same two cytokines were implicated in the protective mechanism, whether thymocytes or peripheral cells were used to prevent autoimmunity, strongly suggests that the regulatory cells from both sources act in the same way and that the thymocytes are programmed in the periphery for their protective role. The implications of this result with respect to immunological homeostasis are discussed.

autoimmunity;  regulatory T cells;  transforming growth factor ;  interleukin 4

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• HIGASHIJIMA, J., SHIMADA, M., CHIKAKIYO, M., MIYATANI, T., YOSHIKAWA, K., NISHIOKA, M., IWATA, T., KURITA, N. (2009). Effect of Splenectomy on Antitumor Immune System in Mice. Anticancer Res 29: 385-393 [Abstract] [Full Text]  
• Poncin, S., Lengele, B., Colin, I. M., Gerard, A.-C. (2008). Differential Interactions between Th1/Th2, Th1/Th3, and Th2/Th3 Cytokines in the Regulation of Thyroperoxidase and Dual Oxidase Expression, and of Thyroglobulin Secretion in Thyrocytes in Vitro. Endocrinology 149: 1534-1542 [Abstract] [Full Text]  
• Luo, X., Zhang, Q., Liu, V., Xia, Z., Pothoven, K. L., Lee, C. (2008). Cutting Edge: TGF-{beta}-Induced Expression of Foxp3 in T cells Is Mediated through Inactivation of ERK. J. Immunol. 180: 2757-2761 [Abstract] [Full Text]  
• Sutmuller, R., Garritsen, A., Adema, G. J (2007). Regulatory T cells and toll-like receptors: regulating the regulators. Ann Rheum Dis 66: iii91-iii95 [Abstract] [Full Text]  
• Tas, S. W., Vervoordeldonk, M. J., Hajji, N., Schuitemaker, J. H. N., van der Sluijs, K. F., May, M. J., Ghosh, S., Kapsenberg, M. L., Tak, P. P., de Jong, E. C. (2007). Noncanonical NF-{kappa}B signaling in dendritic cells is required for indoleamine 2,3-dioxygenase (IDO) induction and immune regulation. Blood 110: 1540-1549 [Abstract] [Full Text]  
• Peng, Y., Shao, H., Ke, Y., Zhang, P., Han, G., Kaplan, H. J., Sun, D. (2007). Minimally Activated CD8 Autoreactive T Cells Specific for IRBP Express a High Level of Foxp3 and Are Functionally Suppressive. IOVS 48: 2178-2184 [Abstract] [Full Text]  
• You, S., Leforban, B., Garcia, C., Bach, J.-F., Bluestone, J. A., Chatenoud, L. (2007). Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment. Proc. Natl. Acad. Sci. USA 104: 6335-6340 [Abstract] [Full Text]  
• Liu, V. C., Wong, L. Y., Jang, T., Shah, A. H., Park, I., Yang, X., Zhang, Q., Lonning, S., Teicher, B. A., Lee, C. (2007). Tumor Evasion of the Immune System by Converting CD4+CD25- T Cells into CD4+CD25+ T Regulatory Cells: Role of Tumor-Derived TGF-beta. J. Immunol. 178: 2883-2892 [Abstract] [Full Text]  
• Hillebrands, J.-L., Whalen, B., Visser, J. T. J., Koning, J., Bishop, K. D., Leif, J., Rozing, J., Mordes, J. P., Greiner, D. L., Rossini, A. A. (2006). A Regulatory CD4+ T Cell Subset in the BB Rat Model of Autoimmune Diabetes Expresses Neither CD25 Nor Foxp3. J. Immunol. 177: 7820-7832 [Abstract] [Full Text]  
• Viehl, C. T., Moore, T. T., Liyanage, U. K., Frey, D. M., Ehlers, J. P., Eberlein, T. J., Goedegebuure, P. S., Linehan, D. C. (2006). Depletion of CD4+CD25+ Regulatory T Cells Promotes a Tumor-Specific Immune Response in Pancreas Cancer-Bearing Mice. Ann. Surg. Oncol. 13: 1252-1258 [Abstract] [Full Text]  
• Toda, A., Piccirillo, C. A. (2006). Development and function of naturally occurring CD4+CD25+ regulatory T cells. J. Leukoc. Biol. 80: 458-470 [Abstract] [Full Text]  
• Fecci, P. E., Sweeney, A. E., Grossi, P. M., Nair, S. K., Learn, C. A., Mitchell, D. A., Cui, X., Cummings, T. J., Bigner, D. D., Gilboa, E., Sampson, J. H. (2006). Systemic Anti-CD25 Monoclonal Antibody Administration Safely Enhances Immunity in Murine Glioma without Eliminating Regulatory T Cells.. Clin. Cancer Res. 12: 4294-4305 [Abstract] [Full Text]  
• Veldhoen, M., Moncrieffe, H., Hocking, R. J., Atkins, C. J., Stockinger, B. (2006). Modulation of Dendritic Cell Function by Naive and Regulatory CD4+ T Cells. J. Immunol. 176: 6202-6210 [Abstract] [Full Text]  
• Zhao, D.-M., Thornton, A. M., DiPaolo, R. J., Shevach, E. M. (2006). Activated CD4+CD25+ T cells selectively kill B lymphocytes. Blood 107: 3925-3932 [Abstract] [Full Text]  
• Kanai, T., Tanimoto, K., Nemoto, Y., Fujii, R., Makita, S., Totsuka, T., Watanabe, M. (2006). Naturally arising CD4+CD25+ regulatory T cells suppress the expansion of colitogenic CD4+CD44highCD62L- effector memory T cells. Am. J. Physiol. Gastrointest. Liver Physiol. 290: G1051-G1058 [Abstract] [Full Text]  
• Dawes, R., Petrova, S., Liu, Z., Wraith, D., Beverley, P. C. L., Tchilian, E. Z. (2006). Combinations of CD45 Isoforms Are Crucial for Immune Function and Disease. J. Immunol. 176: 3417-3425 [Abstract] [Full Text]  
• Kitade, H., Kawai, M., Rutgeerts, O., Landuyt, W., Waer, M., Mathieu, C., Pirenne, J. (2005). Early Presence of Regulatory Cells in Transplanted Rats Rendered Tolerant by Donor-Specific Blood Transfusion. J. Immunol. 175: 4963-4970 [Abstract] [Full Text]  
• You, S., Belghith, M., Cobbold, S., Alyanakian, M.-A., Gouarin, C., Barriot, S., Garcia, C., Waldmann, H., Bach, J.-F., Chatenoud, L. (2005). Autoimmune Diabetes Onset Results From Qualitative Rather Than Quantitative Age-Dependent Changes in Pathogenic T-Cells. Diabetes 54: 1415-1422 [Abstract] [Full Text]  
• Wolf, D., Hochegger, K., Wolf, A. M., Rumpold, H. F., Gastl, G., Tilg, H., Mayer, G., Gunsilius, E., Rosenkranz, A. R. (2005). CD4+CD25+ Regulatory T Cells Inhibit Experimental Anti-Glomerular Basement Membrane Glomerulonephritis in Mice. J. Am. Soc. Nephrol. 16: 1360-1370 [Abstract] [Full Text]  
• Lundsgaard, D., Holm, T. L., Hornum, L., Markholst, H. (2005). In Vivo Control of Diabetogenic T-Cells by Regulatory CD4+CD25+ T-Cells Expressing Foxp3. Diabetes 54: 1040-1047 [Abstract] [Full Text]  
• Poussier, P., Ning, T., Murphy, T., Dabrowski, D., Ramanathan, S. (2005). Impaired Post-Thymic Development of Regulatory CD4+25+ T Cells Contributes to Diabetes Pathogenesis in BB Rats. J. Immunol. 174: 4081-4089 [Abstract] [Full Text]  
• Xystrakis, E., Dejean, A. S., Bernard, I., Druet, P., Liblau, R., Gonzalez-Dunia, D., Saoudi, A. (2004). Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation. Blood 104: 3294-3301 [Abstract] [Full Text]  
• Salam, M. A., Matin, K., Matsumoto, N., Tsuha, Y., Hanada, N., Senpuku, H. (2004). E2f1 Mutation Induces Early Onset of Diabetes and Sjogren's Syndrome in Nonobese Diabetic Mice. J. Immunol. 173: 4908-4918 [Abstract] [Full Text]  
• Bluestone, J. A., Tang, Q. (2004). Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells. Proc. Natl. Acad. Sci. USA 101: 14622-14626 [Abstract] [Full Text]  
• Zhang, X., Koldzic, D. N., Izikson, L., Reddy, J., Nazareno, R. F., Sakaguchi, S., Kuchroo, V. K., Weiner, H. L. (2004). IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells. Int Immunol 16: 249-256 [Abstract] [Full Text]  
• Sempowski, G. D., Cross, S. J., Heinly, C. S., Scearce, R. M., Haynes, B. F. (2004). CD7 and CD28 Are Required for Murine CD4+CD25+ Regulatory T Cell Homeostasis and Prevention of Thyroiditis. J. Immunol. 172: 787-794 [Abstract] [Full Text]  
• Oleszak, E. L., Chang, J. R., Friedman, H., Katsetos, C. D., Platsoucas, C. D. (2004). Theiler's Virus Infection: a Model for Multiple Sclerosis. Clin. Microbiol. Rev. 17: 174-207 [Abstract] [Full Text]  
• Foussat, A., Cottrez, F., Brun, V., Fournier, N., Breittmayer, J.-P., Groux, H. (2003). A Comparative Study between T Regulatory Type 1 and CD4+CD25+ T Cells in the Control of Inflammation. J. Immunol. 171: 5018-5026 [Abstract] [Full Text]  
• Alard, P., Clark, S. L., Kosiewicz, M. M. (2003). Deletion, but not anergy, is involved in TGF-{beta}-treated antigen-presenting cell-induced tolerance. Int Immunol 15: 945-953 [Abstract] [Full Text]  
• Klein, L., Khazaie, K., von Boehmer, H. (2003). In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. USA 100: 8886-8891 [Abstract] [Full Text]  
• Yan, Y., Devos, T., Yu, L., Xia, G., Rutgeerts, O., Goebels, J., Segers, C., Lin, Y., Vandeputte, M., Waer, M. (2003). Pathogenesis of Autoimmunity After Xenogeneic Thymus Transplantation. J. Immunol. 170: 5936-5946 [Abstract] [Full Text]  
• Chen, Z.-m., O'Shaughnessy, M. J., Gramaglia, I., Panoskaltsis-Mortari, A., Murphy, W. J., Narula, S., Roncarolo, M. G., Blazar, B. R. (2003). IL-10 and TGF-{beta} induce alloreactive CD4+CD25- T cells to acquire regulatory cell function. Blood 101: 5076-5083 [Abstract] [Full Text]  
• Barthlott, T., Kassiotis, G., Stockinger, B. (2003). T Cell Regulation as a Side Effect of Homeostasis and Competition. JEM 197: 451-460 [Abstract] [Full Text]  
• Lehmann, J., Huehn, J., de la Rosa, M., Maszyna, F., Kretschmer, U., Krenn, V., Brunner, M., Scheffold, A., Hamann, A. (2002). Expression of the integrin alpha Ebeta 7 identifies unique subsets of CD25+ as well as CD25- regulatory T cells. Proc. Natl. Acad. Sci. USA 99: 13031-13036 [Abstract] [Full Text]  
• Cohen, J. L., Trenado, A., Vasey, D., Klatzmann, D., Salomon, B. L. (2002). CD4+CD25+ Immunoregulatory T Cells: New Therapeutics for Graft-Versus-Host Disease. JEM 196: 401-406 [Abstract] [Full Text]  
• Piccirillo, C. A., Letterio, J. J., Thornton, A. M., McHugh, R. S., Mamura, M., Mizuhara, H., Shevach, E. M. (2002). CD4+CD25+ Regulatory T Cells Can Mediate Suppressor Function in the Absence of Transforming Growth Factor {beta}1 Production and Responsiveness. JEM 196: 237-246 [Abstract] [Full Text]  
• Banz, A., Pontoux, C., Papiernik, M. (2002). Modulation of Fas-Dependent Apoptosis: A Dynamic Process Controlling Both the Persistence and Death of CD4 Regulatory T Cells and Effector T Cells. J. Immunol. 169: 750-757 [Abstract] [Full Text]  
• Singh, R. R., Ebling, F. M., Albuquerque, D. A., Saxena, V., Kumar, V., Giannini, E. H., Marion, T. N., Finkelman, F. D., Hahn, B. H. (2002). Induction of Autoantibody Production Is Limited in Nonautoimmune Mice. J. Immunol. 169: 587-594 [Abstract] [Full Text]  
• Graca, L., Thompson, S., Lin, C.-Y., Adams, E., Cobbold, S. P., Waldmann, H. (2002). Both CD4+CD25+ and CD4+CD25- Regulatory Cells Mediate Dominant Transplantation Tolerance. J. Immunol. 168: 5558-5565 [Abstract] [Full Text]  
• Kingsley, C. I., Karim, M., Bushell, A. R., Wood, K. J. (2002). CD25+CD4+ Regulatory T Cells Prevent Graft Rejection: CTLA-4- and IL-10-Dependent Immunoregulation of Alloresponses. J. Immunol. 168: 1080-1086 [Abstract] [Full Text]  
• Braley-Mullen, H., Chen, K., Wei, Y., Yu, S. (2001). Role of TGF{beta} in Development of Spontaneous Autoimmune Thyroiditis in NOD.H-2h4 Mice. J. Immunol. 167: 7111-7118 [Abstract] [Full Text]  
• Zhai, Y., Shen, X.-D., Lehmann, M., Busuttil, R., Volk, H.-D., Kupiec-Weglinski, J. W. (2001). T Cell Subsets and In Vitro Immune Regulation in ""Infectious"" Transplantation Tolerance. J. Immunol. 167: 4814-4820 [Abstract] [Full Text]  
• Ng, W. F., Duggan, P. J., Ponchel, F., Matarese, G., Lombardi, G., Edwards, A. D., Isaacs, J. D., Lechler, R. I. (2001). Human CD4+CD25+ cells: a naturally occurring population of regulatory T cells. Blood 98: 2736-2744 [Abstract] [Full Text]  
• Davidson, A., Diamond, B. (2001). Autoimmune Diseases. NEJM 345: 340-350 [Full Text]  
• Tisch, R., Wang, B., Atkinson, M. A., Serreze, D. V., Friedline, R. (2001). A Glutamic Acid Decarboxylase 65-Specific Th2 Cell Clone Immunoregulates Autoimmune Diabetes in Nonobese Diabetic Mice. J. Immunol. 166: 6925-6936 [Abstract] [Full Text]  
• Snijders, A., Elferink, D. G., Geluk, A., van der Zanden, A. L., Vos, K., Schreuder, G. M. T., Breedveld, F. C., de Vries, R. R. P., Zanelli, E. H. (2001). An HLA-DRB1-Derived Peptide Associated with Protection Against Rheumatoid Arthritis Is Naturally Processed by Human APCs. J. Immunol. 166: 4987-4993 [Abstract] [Full Text]  
• Noel, C., Florquin, S., Goldman, M., Braun, M. Y. (2001). Chronic exposure to superantigen induces regulatory CD4+ T cells with IL-10-mediated suppressive activity. Int Immunol 13: 431-439 [Abstract] [Full Text]  
• Kamradt, T., Mitchison, N. A. (2001). Tolerance and Autoimmunity. NEJM 344: 655-664 [Full Text]  
• Subra, J.-F., Cautain, B., Xystrakis, E., Mas, M., Lagrange, D., van der Heijden, H., van de Gaar, M.-J., Druet, P., Fournie, G. J., Saoudi, A., Damoiseaux, J. (2001). The Balance Between CD45RChigh and CD45RClow CD4 T Cells in Rats Is Intrinsic to Bone Marrow-Derived Cells and Is Genetically Controlled. J. Immunol. 166: 2944-2952 [Abstract] [Full Text]  
• Kang, H.-C., Ohmori, M., Harii, N., Endo, T., Onaya, T. (2001). Pax-8 Is Essential for Regulation of the Thyroglobulin Gene by Transforming Growth Factor-{beta}1. Endocrinology 142: 267-275 [Abstract] [Full Text]  
• Paul, A. G. A., van Kooten, P. J. S., van Eden, W., van der Zee, R. (2000). Highly Autoproliferative T Cells Specific for 60-kDa Heat Shock Protein Produce IL-4/IL-10 and IFN-{gamma} and Are Protective in Adjuvant Arthritis. J. Immunol. 165: 7270-7277 [Abstract] [Full Text]  
• Field, A.-C., Caccavelli, L., Fillion, J., Kuhn, J., Mandet, C., Druet, P., Bellon, B. (2000). Neonatal induction of tolerance to Th2-mediated autoimmunity in rats. Int Immunol 12: 1467-1477 [Abstract] [Full Text]  
• Lombardi, G., Dunne, P. J., Scheel-Toellner, D., Sanyal, T., Pilling, D., Taams, L. S., Life, P., Lord, J. M., Salmon, M., Akbar, A. N. (2000). Type 1 IFN Maintains the Survival of Anergic CD4+ T Cells. J. Immunol. 165: 3782-3789 [Abstract] [Full Text]  
• ASSEMAN, C., FOWLER, S., POWRIE, F. (2000). Control of Experimental Inflammatory Bowel Disease by Regulatory T cells. Am. J. Respir. Crit. Care Med. 162: S185-189 [Abstract] [Full Text]  
• Zuklys, S., Balciunaite, G., Agarwal, A., Fasler-Kan, E., Palmer, E., Hollander, G. A. (2000). Normal Thymic Architecture and Negative Selection Are Associated with Aire Expression, the Gene Defective in the Autoimmune-Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED). J. Immunol. 165: 1976-1983 [Abstract] [Full Text]  
• Read, S., Malmstrom, V., Powrie, F. (2000). Cytotoxic T Lymphocyte-associated Antigen 4 Plays an Essential Role in the Function of CD25+CD4+ Regulatory Cells that Control Intestinal Inflammation. JEM 192: 295-302 [Abstract] [Full Text]  
• Paul, A. G. A., van der Zee, R., Taams, L. S., van Eden, W. (2000). A self-hsp60 peptide acts as a partial agonist inducing expression of B7-2 on mycobacterial hsp60-specific T cells: a possible mechanism for inhibitory T cell regulation of adjuvant arthritis?. Int Immunol 12: 1041-1050 [Abstract] [Full Text]  
• Suzuki, H., Zhou, Y. W., Kato, M., Mak, T. W., Nakashima, I. (1999). Normal Regulatory {alpha}/{beta} T Cells Effectively Eliminate Abnormally Activated T Cells Lacking the Interleukin 2 Receptor {beta} In Vivo. JEM 190: 1561-1572 [Abstract] [Full Text]  
• Davies, J. D., O'Connor, E., Hall, D., Krahl, T., Trotter, J., Sarvetnick, N. (1999). CD4+ CD45RB Low-Density Cells from Untreated Mice Prevent Acute Allograft Rejection. J. Immunol. 163: 5353-5357 [Abstract] [Full Text]  
• Asseman, C., Mauze, S., Leach, M. W., Coffman, R. L., Powrie, F. (1999). An Essential Role for Interleukin 10 in the Function of Regulatory T Cells That Inhibit Intestinal Inflammation. JEM 190: 995-1004 [Abstract] [Full Text]  
• Gallichan, W. S., Balasa, B., Davies, J. D., Sarvetnick, N. (1999). Pancreatic IL-4 Expression Results in Islet-Reactive Th2 Cells That Inhibit Diabetogenic Lymphocytes in the Nonobese Diabetic Mouse. J. Immunol. 163: 1696-1703 [Abstract] [Full Text]  
• Seddon, B., Mason, D. (1999). Peripheral Autoantigen Induces Regulatory T Cells that Prevent Autoimmunity. JEM 189: 877-882 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS